Selective in vivo mobilization with granulocyte macrophage colony- stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation

Clinical Cancer Research

Volumn 5, Issue 10, 1999, Pages 2735-2741

  Avigan, David ^a,c   Wu, Zekui ^b   Gong, Jianlin ^b   Joyce, Robin ^a   Levine, James ^a   Elias, Anthony ^b   Richardson, Paul ^b   Milano, Joya ^a   Kennedy, Leslie ^a   Anderson, Kenneth ^b   Kufe, Donald ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; KI 67 ANTIGEN; NONSPECIFIC ESTERASE; PACLITAXEL; TAXANE DERIVATIVE;

ADVANCED CANCER; ARTICLE; AUTOTRANSPLANTATION; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IMMUNOTHERAPY; PRIORITY JOURNAL;

ANTIGENS, CD14; BREAST NEOPLASMS; DENDRITIC CELLS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-4; TRANSPLANTATION, AUTOLOGOUS;

EID: 0032695093     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9: 271, 1991.
2. Young, J. W., Koulova, L., Soergel, S. A., Clark, E. A., Steinman, R. M., and Dupont, B. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T-lymphocytes by human blood dendritic cells in vitro. J. Clin. Invest., 90: 229, 1992.
3. Inaba, K., Witmer-Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P. S., Ikehara, S., Muramatsu, S., Hodes, R. J., and Steinman, R. M. The tissue distribution of the B7-2 costimulatory in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med., 180: 1849, 1994.
4. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. Costimulation of antitumor immunity by the B7 counterreceptor for the T-lymphocyte molecules CD28 and CTLI-4. Cell. 71: 1093, 1992.
5. Baskar, S., Ostrand-Rosenberg, S., Nabavi, N., Nadler, L. M., Freeman, G. J., and Glimcher, L. H. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA, 90: 5687, 1993.
6. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., and Allision, J. P. CD28-mediated signaling costimulates murine T cells and prevents induction of energy in T-cell clones. Nature (Lond.), 356: 607, 1992.
7. Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., and Lotze, M. T. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nat. Med., 1: 1297, 1995.
8. Gong, J., Chen, D., Kashiwaba, M., and Kufe, D. Induction of antitumor activity by immunization with fusion of dendritic and carcinoma cells. Nat. Med., 3: 558, 1997.
9. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., and Storkus, W. J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation and T-helper cell 1-associated cytokines. J. Exp. Med., 183: 87, 1996.
10. Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., and Levy, R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med., 2: 52, 1996.
11. Caux, C., Dezutter-Dambuyant, C., Schmitt, D., and Banchereau, J. GM-CSF and TNFα cooperate in the generation of dendritic Langerhans cells. Nature (Lond.), 360: 258, 1992.
12. Markowicz, S., and Engleman, E. G. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J. Clin. Invest., 85: 955, 1990.
13. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor-α. J. Exp. Med., 182: 1111, 1995.
14. 4+ progenitors in human bone marrow. J. Immunol., 149: 2681, 1992.
15. Young, J. W., and Steinman, R. M. The hematopoietic development of dendritic cells: a distinct pathway of myeloid differentiation. Stem Cells, 14: 376, 1996.
16. Witmer-Pack, M. D., Olivier, W., Valinsky, J., Schuler, G., and Steinman, R. M. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med., 166: 1484, 1987.
17. Heufler, C., Koch, F., and Schuler, G. Granulocyte/macrophage colony-stimulating factor and interleukin-1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med., 167: 700, 1988.
18. Inaba, K., Inaba, M., Romani, N., Ayu, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R. M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med., 176: 1693, 1992.
19. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF α. 184: 695, 1996.
20. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNFI. J. Immunol., 154: 5851, 1995.
21. + hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res., 55: 1099, 1995.
22. Romani, N., Gruner, S., Brang, D., Kampsgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., and Schuler, G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med., 180: 83, 1994.
23. Romani, N., Koide, S., Crowley, M., Pack, M. W., Livingstone, A. M., Fathman, C. G., Inaba, K., and Steinman, R. M. Presentation of exogenous protein antigens by dendritic cells to T-cell clones: intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med., 168: 1169, 1989.
24. Szabolcs, P., Avigan, D., Gezetlter, S., Ciocon, D. H., Moor, M. A., Steinman, R. M., and Young, J. W. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post CPU intermediate. Blood, 87: 4520, 1996.
25. Sheridan, W. P., Begley, C. G., Jutner, C. A., Szer, J., To, L. B., Maher, D., McGrath, K. M., Morstyn, G., and Fox, R. M. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet, 339: 640, 1992.
26. + dendritic cells. Proc. Natl. Acad. Sci. USA, 93: 2588, 1996.
27. Taite, K., Lu, Z. Y., Fiol, G., Legouffe, E., Rossi, J. F., and Klein, B. Generation of virtually pure and potentially proliferating dendritic cells from patients with multiple myeloma. Blood, 90: 3482, 1997.
28. Siena, S., Di Nicola, M., Bregni, M., Mortarini, R., Anichini, A., Lombardi, L., Ravagnani, F., Parmiani, G., and Gianni, A. M. Massive ex vivo generation of functional dendritic cells from mobilized cd34 + blood progenitors for anticancer therapy. Exp. Hematol., 23: 1463, 1995.